DEFA14A: Xenetic Biosciences Sets Date for Annual Stockholder Meeting, Outlines Voting Proposals

Xenetic Biosciences announces its annual stockholder meeting to be held on December 11, 2024, outlining key proposals for voting, including the election of directors and ratification of the company's accounting firm.

Summary

• Xenetic Biosciences, Inc. will hold its annual stockholder meeting on December 11, 2024.
• Stockholders are invited to vote on several key proposals.
• These proposals include the election of six directors: Grigory Borisenko, Firdaus Jal Dastoor, Dmitry Genkin, Roger Kornberg, Moshe Mizrahy, and Alexey Vinogradov.
• Another proposal involves ratifying the selection of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• Additionally, there will be a non-binding advisory vote to approve the company's named executive officer compensation.
• Stockholders will also vote on the frequency of future votes regarding executive officer compensation.
• Proxy materials, including the Proxy Statement, Form 10-K, and Form 10-K/A, are available online.
• Stockholders can request a free paper or email copy of these materials before November 27, 2024.
• The deadline to vote is December 10, 2024, at 11:59 PM ET.
• The meeting will be held virtually at www.virtualshareholdermeeting.com/XBIO2024.

Sentiment

Score: 7

Explanation: The document is a routine announcement regarding the annual stockholder meeting, presenting neutral information about voting proposals and meeting logistics. It doesn't contain any particularly positive or negative news, hence the neutral sentiment.

Positives

• The company is providing stockholders with multiple avenues to access proxy materials and cast their votes, including online access, mail requests, and email requests.
• The proposals are clearly outlined, allowing stockholders to make informed decisions.

Future Outlook

The document outlines the matters to be voted on at the upcoming annual meeting, which will influence the company's governance and financial oversight for the coming year.

Industry Context

This announcement is a standard part of corporate governance, ensuring that shareholders have the opportunity to participate in key decisions regarding the company's direction and oversight.

Stakeholder Impact

• Shareholders have the opportunity to influence the company's direction through voting on key proposals.
• The outcome of the votes will impact the composition of the board of directors and the selection of the company's accounting firm.

Next Steps

• Stockholders should review the proxy materials and cast their votes before the December 10, 2024 deadline.
• Attend the virtual annual meeting on December 11, 2024.

Key Dates

Keywords

stockholder meeting, proxy statement, annual meeting, election of directors, Marcum LLP, executive compensation, voting, Xenetic Biosciences